- Home
- AEYE vs SGMO Comparison
AEYE vs SGMO Comparison
Compare AEYE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEYE | SGMO |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9M | 141.2M |
| IPO Year | 2011 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AEYE | SGMO |
|---|---|---|
| Price | $6.57 | $0.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $20.67 | $5.75 |
| AVG Volume (30 Days) | 162.2K | ★ 7.9M |
| Earning Date | 04-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.00 | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | $35,201,000.00 | ★ $36,567,000.00 |
| Revenue This Year | $16.81 | $4.79 |
| Revenue Next Year | $11.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.41 | ★ 88.60 |
| 52 Week Low | $6.35 | $0.35 |
| 52 Week High | $16.39 | $1.06 |
Technical Indicators
Market Signals| Indicator | AEYE | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 25.77 | 48.39 |
| Support Level | N/A | $0.38 |
| Resistance Level | $12.82 | $0.57 |
| Average True Range (ATR) | 0.54 | 0.04 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 7.69 | 36.65 |
Price Performance
Historical ComparisonAbout AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.